"
Team:Uppsala/toxin-antitoxin-system
From 2013.igem.org
(Difference between revisions)
(Created page with "{{Team:Uppsala/standard-style}} {{Team:Uppsala/tat-style}} <html> <head> <meta charset="utf-8" /> <title>Uppsala iGEM 2013</title> <link rel="shortcut icon" href="favicon.ic...") |
|||
| (19 intermediate revisions not shown) | |||
| Line 1: | Line 1: | ||
| - | |||
{{Team:Uppsala/tat-style}} | {{Team:Uppsala/tat-style}} | ||
| + | {{Team:Uppsala/standard-style-no-frame}} | ||
<html> | <html> | ||
| Line 12: | Line 12: | ||
</style> | </style> | ||
| + | |||
| + | <script type="text/javascript"> | ||
| + | /*Acts once the document is loaded*/ $(document).ready(function() { /*Move the tn-main-wrap as child of <body>*/ $("#tn-main-wrap-wrap").prependTo($("body")); /*Move the menubars in the tn-main-wrap*/ $("#menubar.left-menu").appendTo($("#tn-main-wrap")); $("#menubar.right-menu").appendTo($("#tn-main-wrap")); | ||
| + | /*Spoiler JS*/ $(".tn-spoiler div").slideUp(); $(".tn-spoiler a").click(function(e) { e.preventDefault(); $(".tn-spoiler-active").removeClass("tn-spoiler-active"); $(this).parent().addClass("tn-spoiler-active"); $(".tn-spoiler").not(".tn-spoiler-active").children("div").slideUp(); $(".tn-spoiler-active").children("div").slideToggle(); }); | ||
| + | /*Add favicon*/ $("link[rel='shortcut icon']").remove(); $("head").append("<link rel='shortcut icon' type='image/png' href='https://static.igem.org/mediawiki/2013/6/6d/Uppsalas-cow-con.png'>"); }); | ||
| + | </script> | ||
| + | |||
| + | <link href="https://2013.igem.org/Team:Uppsala/lightbox-css-code.css?action=raw&ctype=text/css" type="text/css" rel="stylesheet"> | ||
| + | |||
| + | <script src="https://2013.igem.org/Team:Uppsala/jquery-code.js?action=raw&ctype=text/javascript" type="text/javascript"></script> | ||
| + | |||
| + | <script src="https://2013.igem.org/Team:Uppsala/lightbox-code.js?action=raw&ctype=text/javascript" type="text/javascript"></script> | ||
</head> | </head> | ||
| Line 26: | Line 38: | ||
<!-- Contains sub-logo picture --> | <!-- Contains sub-logo picture --> | ||
| - | <div id="igem_logo"><a href="https://2013.igem.org/ | + | <div id="igem_logo"><a href="https://2013.igem.org/Team:Uppsala"><img class="igem_logo" src="https://static.igem.org/mediawiki/2013/e/e0/Uppsala2013_IGEMlogo.png"></a></div> |
| - | <div id="igem"><a href="https://2013.igem.org/Main_Page"><img class="igem" src="https://static.igem.org/mediawiki/2013/ | + | <div id="igem"><a href="https://2013.igem.org/Main_Page"><img class="igem" src="https://static.igem.org/mediawiki/2013/b/b8/Uppsala2013_Uppsala_IGEM_log_blue.png"></a></div> |
| + | |||
| + | <img class="slogan" src="https://static.igem.org/mediawiki/2013/a/ad/Uppsala2013_Header.png"> | ||
</div> | </div> | ||
| Line 43: | Line 57: | ||
<li><a href="https://2013.igem.org/Team:Uppsala/project" id="list_type1"><img class="nav-text" src="https://static.igem.org/mediawiki/2013/a/aa/Uppsala2013_Project.png"></a> | <li><a href="https://2013.igem.org/Team:Uppsala/project" id="list_type1"><img class="nav-text" src="https://static.igem.org/mediawiki/2013/a/aa/Uppsala2013_Project.png"></a> | ||
<ul> | <ul> | ||
| - | + | ||
<li><a href="https://2013.igem.org/Team:Uppsala/chassi">Chassi</a> | <li><a href="https://2013.igem.org/Team:Uppsala/chassi">Chassi</a> | ||
<ul> | <ul> | ||
| Line 49: | Line 63: | ||
<li><a href="https://2013.igem.org/Team:Uppsala/promoters">Promoters</a></li> | <li><a href="https://2013.igem.org/Team:Uppsala/promoters">Promoters</a></li> | ||
<li><a href="https://2013.igem.org/Team:Uppsala/reporter-genes">Reporter genes</a></li> | <li><a href="https://2013.igem.org/Team:Uppsala/reporter-genes">Reporter genes</a></li> | ||
| - | <li><a href="https://2013.igem.org/Team:Uppsala/ | + | <li><a href="https://2013.igem.org/Team:Uppsala/toxin-antitoxin-system">Toxin-antitoxin system</a></li> |
<li><a href="https://2013.igem.org/Team:Uppsala/vectors">Vectors</a></li> | <li><a href="https://2013.igem.org/Team:Uppsala/vectors">Vectors</a></li> | ||
<li><a href="https://2013.igem.org/Team:Uppsala/signal-peptide">Signal peptide</a></li> | <li><a href="https://2013.igem.org/Team:Uppsala/signal-peptide">Signal peptide</a></li> | ||
| Line 56: | Line 70: | ||
<li><a href="https://2013.igem.org/Team:Uppsala/metabolic-engineering">Metabolic engineering</a> | <li><a href="https://2013.igem.org/Team:Uppsala/metabolic-engineering">Metabolic engineering</a> | ||
<ul> | <ul> | ||
| - | <li><a href="https://2013.igem.org/Team:Uppsala/p-coumaric-acid"> | + | <li><a href="https://2013.igem.org/Team:Uppsala/p-coumaric-acid">p-Coumaric acid</a></li> |
<li><a href="https://2013.igem.org/Team:Uppsala/resveratrol">Resveratrol</a></li> | <li><a href="https://2013.igem.org/Team:Uppsala/resveratrol">Resveratrol</a></li> | ||
<li><a href="https://2013.igem.org/Team:Uppsala/lycopene">Lycopene</a></li> | <li><a href="https://2013.igem.org/Team:Uppsala/lycopene">Lycopene</a></li> | ||
| Line 62: | Line 76: | ||
<li><a | <li><a | ||
href="https://2013.igem.org/Team:Uppsala/saffron">Saffron</a></li> | href="https://2013.igem.org/Team:Uppsala/saffron">Saffron</a></li> | ||
| - | <li><a href="https://2013.igem.org/Team:Uppsala/ | + | <li><a href="https://2013.igem.org/Team:Uppsala/astaxanthin">Astaxanthin</a></li> |
| - | <li><a href="https://2013.igem.org/Team:Uppsala/ | + | <li><a href="https://2013.igem.org/Team:Uppsala/zeaxanthin">Zeaxanthin</a></li> |
</ul></li> | </ul></li> | ||
</li> | </li> | ||
| Line 69: | Line 83: | ||
href="https://2013.igem.org/Team:Uppsala/miraculin">Miraculin</a></li> | href="https://2013.igem.org/Team:Uppsala/miraculin">Miraculin</a></li> | ||
<li><a href="https://2013.igem.org/Team:Uppsala/chromoproteins">Chromoproteins</a></li> | <li><a href="https://2013.igem.org/Team:Uppsala/chromoproteins">Chromoproteins</a></li> | ||
| - | <li><a href="https://2013.igem.org/Team:Uppsala/safety">Safety experiment</a></li> | + | <li><a href="https://2013.igem.org/Team:Uppsala/safety-experiment">Safety experiment</a></li> |
| - | <li><a href="https://2013.igem.org/Team:Uppsala/ | + | <li><a href="https://2013.igem.org/Team:Uppsala/results">Results</a></li> |
| Line 77: | Line 91: | ||
<li><a href="https://2013.igem.org/Team:Uppsala/modeling" id="list_type1"><img class="nav-text" src="https://static.igem.org/mediawiki/2013/6/63/Uppsala2013_Modeling.png"></a> | <li><a href="https://2013.igem.org/Team:Uppsala/modeling" id="list_type1"><img class="nav-text" src="https://static.igem.org/mediawiki/2013/6/63/Uppsala2013_Modeling.png"></a> | ||
<ul> | <ul> | ||
| - | <li><a href="https://2013.igem.org/Team:Uppsala/ | + | <li><a href="https://2013.igem.org/Team:Uppsala/P-Coumaric-acid-pathway">Kinetic model</a></li> |
<li><a href="https://2013.igem.org/Team:Uppsala/modeling-tutorial">Modeling tutorial </a></li> | <li><a href="https://2013.igem.org/Team:Uppsala/modeling-tutorial">Modeling tutorial </a></li> | ||
| + | |||
| + | <li><a href="https://2013.igem.org/Team:Uppsala/toxicity-model">Toxicity model</a></li> | ||
</ul></li> | </ul></li> | ||
<li><a href="https://2013.igem.org/Team:Uppsala/parts" id="list_type2"><img class="nav-text" src="https://static.igem.org/mediawiki/2013/e/eb/Uppsala2013_parts.png"></a></li> | <li><a href="https://2013.igem.org/Team:Uppsala/parts" id="list_type2"><img class="nav-text" src="https://static.igem.org/mediawiki/2013/e/eb/Uppsala2013_parts.png"></a></li> | ||
| Line 87: | Line 103: | ||
<li><a href="https://2013.igem.org/Team:Uppsala/carotenoid-group">Carotenoid group</a></li> | <li><a href="https://2013.igem.org/Team:Uppsala/carotenoid-group">Carotenoid group</a></li> | ||
<li><a href="https://2013.igem.org/Team:Uppsala/chassi-group">Chassi group</a></li> | <li><a href="https://2013.igem.org/Team:Uppsala/chassi-group">Chassi group</a></li> | ||
| - | + | <li><a href="https://2013.igem.org/Team:Uppsala/advisors">Advisors</a></li> | |
| + | |||
</ul></li> | </ul></li> | ||
| - | <li><a href="https://2013.igem.org/Team:Uppsala/ | + | <li><a href="https://2013.igem.org/Team:Uppsala/human-practice" id="list_type3"><img class="nav-text" src="https://static.igem.org/mediawiki/2013/b/b8/Uppsala2013_HP.png"></a> |
<ul> | <ul> | ||
| - | <li><a href="https://2013.igem.org/Team:Uppsala/ | + | <li><a href="https://2013.igem.org/Team:Uppsala/yoghurt">Yoghurt +</a></li> |
| - | <li><a href="https://2013.igem.org/Team:Uppsala/synbioday"> | + | <li><a href="https://2013.igem.org/Team:Uppsala/synbioday">SynBioDay</a></li> |
| - | <li><a href="https://2013.igem.org/Team:Uppsala/ | + | <li><a href="https://2013.igem.org/Team:Uppsala/biosafety-and-ethics">Biosafety and ethics</a></li> |
| - | <li><a href="https://2013.igem.org/Team:Uppsala/ | + | <li><a href="https://2013.igem.org/Team:Uppsala/public-opinion">Public opinion </a></li> |
| - | + | <li><a href="https://2013.igem.org/Team:Uppsala/Outreach">High school & media </a></li> | |
| - | + | <li><a href="https://2013.igem.org/Team:Uppsala/bioart">BioArt</a></li> | |
| + | <li><a href="https://2013.igem.org/Team:Uppsala/LactonutritiousWorld">A LactoWorld</a></li> | ||
| + | <li><a href="https://2013.igem.org/Team:Uppsala/killswitches">Killswitches</a></li> | ||
| + | <li><a href="https://2013.igem.org/Team:Uppsala/realization">Patent</a></li> | ||
</ul></li> | </ul></li> | ||
<li><a href="https://2013.igem.org/Team:Uppsala/attribution" id="list_type4"><img class="nav-text" src="https://static.igem.org/mediawiki/2013/5/5d/Uppsala2013_Attributions.png"></a></li> | <li><a href="https://2013.igem.org/Team:Uppsala/attribution" id="list_type4"><img class="nav-text" src="https://static.igem.org/mediawiki/2013/5/5d/Uppsala2013_Attributions.png"></a></li> | ||
<li><a href="https://2013.igem.org/Team:Uppsala/notebook" id="list_type3"><img class="nav-text" src="https://static.igem.org/mediawiki/2013/3/36/Uppsala2013_Notebook.png"></a> | <li><a href="https://2013.igem.org/Team:Uppsala/notebook" id="list_type3"><img class="nav-text" src="https://static.igem.org/mediawiki/2013/3/36/Uppsala2013_Notebook.png"></a> | ||
<ul> | <ul> | ||
| - | <li><a href="https://2013.igem.org/Team:Uppsala/ | + | <li><a href="https://2013.igem.org/Team:Uppsala/safety-form">Safety form</a></li> |
| - | <li><a href="https://2013.igem.org/Team:Uppsala/ | + | <li><a href="https://2013.igem.org/Team:Uppsala/protocols">Protocols</a></li> |
</ul></li> | </ul></li> | ||
</ul> | </ul> | ||
| - | </div> | + | </div> |
</div> | </div> | ||
| - | |||
<div id="main_content"> <!-- Put content here --> | <div id="main_content"> <!-- Put content here --> | ||
| - | <h1 class="main-title"> Toxin-antitoxin system </h1> | + | <h1 class="main-title-left"> Toxin-antitoxin system </h1> |
| - | + | ||
| - | < | + | <img class="symbol-pic" src="https://static.igem.org/mediawiki/2013/1/12/Uppsala2013_toxin-antitoxin_symbol_mini.png"> |
| + | |||
| + | <div id="clear"></div> | ||
| + | |||
| + | <a id="b1"></a> | ||
| + | <h1> Keep your plasmids without antibiotic resistance </h1> | ||
One of the challenges when creating synthetic systems in bacteria that serve a purpose besides increasing the fitness of the organism is that there is a negative selective pressure against keeping the system. Toxin-antitoxin systems can be used to make plasmids far more stabile without having to use antibiotics and antibiotic resistance. If a clone were to lose the plasmid, the toxin which usually has a longer half life than the antitoxin will kill the bacteria. | One of the challenges when creating synthetic systems in bacteria that serve a purpose besides increasing the fitness of the organism is that there is a negative selective pressure against keeping the system. Toxin-antitoxin systems can be used to make plasmids far more stabile without having to use antibiotics and antibiotic resistance. If a clone were to lose the plasmid, the toxin which usually has a longer half life than the antitoxin will kill the bacteria. | ||
| - | < | + | <a href="https://static.igem.org/mediawiki/2013/d/dc/Uppsala2013_anti-toxin-toxin-system.jpg" data-lightbox="roadtrip"><img class="method-plasmid" src="https://static.igem.org/mediawiki/2013/d/dc/Uppsala2013_anti-toxin-toxin-system.jpg"></a> |
| - | < | + | |
| - | < | + | <p>Above is an example of how a toxin-antitoxin system could be applied together with a gene X. If the gene is toxic or expressed strongly enough there will be a substantial evolutionary pressure to lose the plasmid during cell division. However if the gene is present on a plasmid with a toxin-antitoxin system would be lethal due to the loss of the antitoxin gene.</p> |
| - | We have taken the Pem toxin-antitoxin system from plasmid p256 that was originally isolated from lactobacillus plantarum NC7. The system consists of a single operon and consists of two ORFs, one for the toxin and antitoxin respectively. Pem on p256 has been shown to increase segregational stability under non-selective pressure. The system has experimentally been shown to allow 88-100% retention of a plasmid after 80 generations | + | |
| + | <h1> A natural toxin-antitoxin from lactobacillus plantarum </h1> | ||
| + | We have taken the Pem toxin-antitoxin system from plasmid p256 that was originally isolated from lactobacillus plantarum NC7. The system consists of a single operon and consists of two ORFs, one for the toxin and antitoxin respectively. Pem on p256 has been shown to increase segregational stability under non-selective pressure. The system has experimentally been shown to allow 88-100% retention of a plasmid after 80 generations<sup> <a href="#refpoint"> [1] </a> </sup>. We have provided the toxin-antitoxin system both with and without a natural putative promoter. | ||
<br> | <br> | ||
<br> | <br> | ||
| - | < | + | <h1> Biobricks </h1> |
| - | http://mic.sgmjournals.org/content/151/2/421.long | + | <li> <a href="http://parts.igem.org/Part:BBa_K1033259">BBa_K1033259</a> - antitoxin system from lactobacillus plantarum Toxin<br> </li> |
| + | <li> <a href="http://parts.igem.org/Part:BBa_K1033260">BBa_K1033260</a> - antitoxin system from Lactobacillus plantarum Toxin<br> </li> | ||
| + | |||
| + | <h1> References: </h1> <a id="refpoint"> | ||
| + | [1] </a> Plasmid p256 from Lactobacillus plantarum represents a new type of replicon in lactic acid bacteria, and contains a toxin–antitoxin-like plasmid maintenance system, Microbiology, <a href="http://mic.sgmjournals.org/content/151/2/421.long"> Elisabeth Sorvig et al. September 30 2004 </a> | ||
| Line 133: | Line 162: | ||
<div id="bottom-pic"> | <div id="bottom-pic"> | ||
| - | + | ||
</div> | </div> | ||
Latest revision as of 21:28, 28 October 2013
Toxin-antitoxin system
Keep your plasmids without antibiotic resistance
One of the challenges when creating synthetic systems in bacteria that serve a purpose besides increasing the fitness of the organism is that there is a negative selective pressure against keeping the system. Toxin-antitoxin systems can be used to make plasmids far more stabile without having to use antibiotics and antibiotic resistance. If a clone were to lose the plasmid, the toxin which usually has a longer half life than the antitoxin will kill the bacteria.
Above is an example of how a toxin-antitoxin system could be applied together with a gene X. If the gene is toxic or expressed strongly enough there will be a substantial evolutionary pressure to lose the plasmid during cell division. However if the gene is present on a plasmid with a toxin-antitoxin system would be lethal due to the loss of the antitoxin gene.
